Lipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer
Abstract Docosahexaenoic acid (DHA) is known to inhibit breast cancer in the rat. Here we investigated whether DHA itself or select metabolites can account for its antitumor action. We focused on metabolites derived from the lipoxygenase (LOX) pathway since we previously showed that they were superi...
Saved in:
Main Authors: | Kun-Ming Chen, Henry Thompson, John P. Vanden-Heuvel, Yuan-Wan Sun, Neil Trushin, Cesar Aliaga, Krishne Gowda, Shantu Amin, Bruce Stanley, Andrea Manni, Karam El-Bayoumy |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c4bb46a811624f08af671d39c0e3ef81 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword
by: Mohammad Amin Vaezi, et al.
Published: (2021) -
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase
by: Helmut Pein, et al.
Published: (2018) -
Catalyzed Synthesis of Zinc Clays by Prebiotic Central Metabolites
by: Ruixin Zhou, et al.
Published: (2017) -
Erratum: Catalyzed Synthesis of Zinc Clays by Prebiotic Central Metabolites
by: Ruixin Zhou, et al.
Published: (2017) -
Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
by: Kumar Reddy Kakularam, et al.
Published: (2022)